找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Neuroimmunology; Multiple Sclerosis, Amanda L. Piquet,Enrique Alvarez Book 2021 Springer Nature Switzerland AG 2021 Neuroimmunology.Multip

[复制链接]
查看: 7304|回复: 58
发表于 2025-3-21 17:22:13 | 显示全部楼层 |阅读模式
书目名称Neuroimmunology
副标题Multiple Sclerosis,
编辑Amanda L. Piquet,Enrique Alvarez
视频videohttp://file.papertrans.cn/665/664101/664101.mp4
概述Focuses on various neuroinflammatory diseases, including multiple sclerosis, immune-mediated neurological diseases and autoimmune neurological disease.Reviews pathophysiology and treatment approaches.
图书封面Titlebook: Neuroimmunology; Multiple Sclerosis,  Amanda L. Piquet,Enrique Alvarez Book 2021 Springer Nature Switzerland AG 2021 Neuroimmunology.Multip
描述.This book provides a clinical focus on neuroinflammatory diseases as well as a review in pathophysiology and treatment approaches...Organized into six parts, the book begins with a basic review of the immune system and concepts for learning and treating neuroimmune conditions. The next four sections cover specific subfields of neuroimmunology and autoimmune neurology - the clinical and diagnostic features of multiple sclerosis, other autoimmune conditions of the central nervous system, autoimmune conditions of the peripheral nervous system, and systemic autoimmune conditions that affect the nervous system. To conclude, Section six discusses various clinical approaches to specific presentations in neuroimmunology, including pediatric demyelinating diseases.  These sections provide practical clinical information to improve the reader’s knowledge in this complex field. The chapters are written by world renown authors with extensive knowledge to help provide up to date information. The full scope of autoimmune neurology is discussed, which is a unique feature of this book...Neuroimmunology. serves as a resource for those in training including residents and fellows to provide clear cli
出版日期Book 2021
关键词Neuroimmunology; Multiple Sclerosis; Autoimmune Neurology; Immunology; Central Nervous System inflammato
版次1
doihttps://doi.org/10.1007/978-3-030-61883-4
isbn_softcover978-3-030-61885-8
isbn_ebook978-3-030-61883-4
copyrightSpringer Nature Switzerland AG 2021
The information of publication is updating

书目名称Neuroimmunology影响因子(影响力)




书目名称Neuroimmunology影响因子(影响力)学科排名




书目名称Neuroimmunology网络公开度




书目名称Neuroimmunology网络公开度学科排名




书目名称Neuroimmunology被引频次




书目名称Neuroimmunology被引频次学科排名




书目名称Neuroimmunology年度引用




书目名称Neuroimmunology年度引用学科排名




书目名称Neuroimmunology读者反馈




书目名称Neuroimmunology读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:38:39 | 显示全部楼层
发表于 2025-3-22 03:22:59 | 显示全部楼层
发表于 2025-3-22 05:01:45 | 显示全部楼层
https://doi.org/10.1007/978-3-030-61883-4Neuroimmunology; Multiple Sclerosis; Autoimmune Neurology; Immunology; Central Nervous System inflammato
发表于 2025-3-22 09:06:12 | 显示全部楼层
发表于 2025-3-22 13:51:18 | 显示全部楼层
发表于 2025-3-22 19:29:47 | 显示全部楼层
Neuroimaging Modalities in Neuroimmunologyple sclerosis (MS). MRI is highly sensitive to visualize white matter signal abnormalities on T2-weighted images, and the characteristic appearance of demyelinating lesions has become well recognized. However, MRI is not pathologically specific, and differentiating MS from other (non-MS) conditions
发表于 2025-3-22 21:21:27 | 显示全部楼层
Clinical Trial Design in Neuroimmunologyd great insights into these conditions resulting in the approval of disease-modifying therapies (DMTs) for multiple sclerosis (MS) and neuromyelitis optica spectrum disease (NMOSD) along with symptomatic therapies such as dalfampridine. Treatment of relapsing-remitting MS (RRMS) has seen dramatic ch
发表于 2025-3-23 02:25:43 | 显示全部楼层
Concepts of Immune Therapy and Disease Managementd should be promptly recognized for early treatment and optimization of chronic immunomodulating or immunosuppressing therapies to avoid disability accumulation over time. Detection of subclinical activity using paraclinical testing also warrants a change in treatment and should be part of the monit
发表于 2025-3-23 08:11:02 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-21 20:40
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表